Homegrown firms are quickly moving via Phase 3 trials to challenge early market leaders, ensuring that Chinese companies will secure a major foothold in one of the world's fastest-growing drug classes
This accessibility gap has driven consumer search behavior in predictable directions
This FDA-approved medication ensures maximum weight loss at 20% in a single year
J Pharmacol Exp Ther 311:99108 Clancy RM, Levartovsky D, Leszczynska-Piziak J, Yegudin J, Abramson SB (1994) Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophils: evidence for S-nitrosoglutathione as a bioactive intermediary
CONCLUSION This work was supported by the Young Investigator Award 2011 from the Korean Diabetes Association and the Korea Science and Engineering Foundation by the Ministry of Education, Science and Technology (S-2010-1115-000) to Won-Young Lee
The incidence typically decreases over time as the body adapts to the medication, with many patients reporting improvement after several weeks at a stable dose